(Q37825339)

23 August 2017

1 reference

title

Exploiting tyrosinase expression and activity in melanocytic tumors: quercetin and the central role of p53. (English)

1 reference

23 August 2017

6

0 references

author name string

Ashley J Vargas

1

1 reference

23 August 2017

Sivanandane Sittadjody

2

1 reference

23 August 2017

Thilakavathy Thangasamy

3

1 reference

23 August 2017

Erin E Mendoza

4

1 reference

23 August 2017

Kirsten H Limesand

5

1 reference

23 August 2017

publication date

31 December 2010

1 reference

Integrative Cancer Therapies

23 August 2017

published in

1 reference

23 August 2017

volume

10

1 reference

23 August 2017

issue

4

1 reference

23 August 2017

page(s)

328-340

1 reference

Melanoma biology and new targeted therapy

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

Synthesis and analysis of urea and carbamate prodrugs as candidates for melanocyte-directed enzyme prodrug therapy (MDEPT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

Melanogenesis-targeted anti-melanoma pro-drug development: effect of side-chain variations on the cytotoxicity of tyrosinase-generated ortho-quinones in a model screening system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

Prodrug cancer gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

Self-tolerance to the murine homologue of a tyrosinase-derived melanoma antigen: implications for tumor immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

Boosting T cell-mediated immunity to tyrosinase by vaccinia virus-transduced, CD34(+)-derived dendritic cell vaccination: a phase I trial in metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

A phase I vaccination study with tyrosinase in patients with stage II melanoma using recombinant modified vaccinia virus Ankara (MVA-hTyr).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

In vitro studies of 2,4-dihydroxyphenylalanine, a prodrug targeted against malignant melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

4-S-cysteaminylphenol and its analogues as substrates for tyrosinase and monoamine oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

Mechanism(s) regulating inhibition of thymidylate synthase and growth by gamma-L-glutaminyl-4-hydroxy-3-iodobenzene, a novel melanin precursor, in melanogenic melanoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

Tyrosinase activated melanoma prodrugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

The early steps of neural crest development

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

Mechanisms of ultraviolet light-induced pigmentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

Regulation of melanogenesis--controversies and new concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

Structural organization of the human tyrosinase gene and sequence analysis and characterization of its promoter region

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

Microphthalmia-associated transcription factor as a regulator for melanocyte-specific transcription of the human tyrosinase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

Central role of p53 in the suntan response and pathologic hyperpigmentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

Neuroblastoma: biological insights into a clinical enigma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

The epidemiology of neuroblastoma: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

Infant cancer in the U.S.: histology-specific incidence and trends, 1973 to 1992.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

Human glioblastoma ADF cells express tyrosinase, L-tyrosine hydroxylase and melanosomes and are sensitive to L-tyrosine and phenylthiourea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

Hyperubiquitylation of wild-type p53 contributes to cytoplasmic sequestration in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

The intricacies of p21 phosphorylation: protein/protein interactions, subcellular localization and stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma: a phase III study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

Insights into pharmacotherapy of malignant glioma in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

The treatment of brain metastases from malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

Indirect oxidation of the antitumor agent procarbazine by tyrosinase--possible application in designing anti-melanoma prodrugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

Quercetin selectively inhibits bioreduction and enhances apoptosis in melanoma cells that overexpress tyrosinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

Hormesis and synergy: pathways and mechanisms of quercetin in cancer prevention and management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

Antioxidative flavonoid quercetin: implication of its intestinal absorption and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

Influence of quercetin and rutin on growth and antioxidant defense system of a human hepatoma cell line (HepG2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

Quercetin pharmacokinetics in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

Dietary flavonoids: effects on xenobiotic and carcinogen metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

Potential synergism of natural products in the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

Selective incorporation and specific cytocidal effect as the cellular basis for the antimelanoma action of sulphur containing tyrosine analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

Identification of o-quinone/quinone methide metabolites of quercetin in a cellular in vitro system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

Quercetin enhances melanogenesis by increasing the activity and synthesis of tyrosinase in human melanoma cells and in normal human melanocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

Quercetin-induced melanogenesis in a reconstituted three-dimensional human epidermal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

p53, the cellular gatekeeper for growth and division

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

Death squads enlisted by the tumour suppressor p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

Tyrosinase gene expression is regulated by p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

p73: Friend or foe in tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

p63 and p73 in human cancer: defining the network

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

TAp73/Delta Np73 influences apoptotic response, chemosensitivity and prognosis in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

Expression of p73 and its relation to histopathology and prognosis in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

Expression of p73, a novel protein related to the p53 tumour suppressor p53, and apoptosis in cholangiocellular carcinoma of the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

DeltaN-p73alpha accumulates in human neuroblastic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

Quercetin abrogates chemoresistance in melanoma cells by modulating deltaNp73.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

Triggering and modulation of apoptosis by oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

The isoflavonoids genistein and quercetin activate different stress signaling pathways as shown by analysis of site-specific phosphorylation of ATM, p53 and histone H2AX.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

No PUMA, no death: implications for p53-dependent apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

PUMA, a novel proapoptotic gene, is induced by p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

Role of p53, PUMA, and Bax in wogonin-induced apoptosis in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

Role of p53 up-regulated modulator of apoptosis and phosphorylated Akt in melanoma cell growth, apoptosis, and patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

Effects of low dose quercetin: cancer cell-specific inhibition of cell cycle progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

Growth inhibitory effects of quercetin on bladder cancer cell.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

The p53 pathway and its inactivation in neuroblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

Regulation of survivin and Bcl-2 in HepG2 cell apoptosis induced by quercetin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

Cytotoxicity of flavones and flavonols to a human esophageal squamous cell carcinoma cell line (KYSE-510) by induction of G2/M arrest and apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

The dietary bioflavonoid, quercetin, selectively induces apoptosis of prostate cancer cells by down-regulating the expression of heat shock protein 90.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

The BH3-only member Noxa causes apoptosis in melanoma cells by multiple pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

Therapeutic efficacy of PUMA for malignant glioma cells regardless of p53 status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

Enhanced killing of melanoma cells by simultaneously targeting Mcl-1 and NOXA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

Endoplasmic reticulum stress-induced apoptosis: multiple pathways and activation of p53-up-regulated modulator of apoptosis (PUMA) and NOXA by p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

Up-regulation of Bcl-2 homology 3 (BH3)-only proteins by E2F1 mediates apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

Role of Noxa in p53-independent fenretinide-induced apoptosis of neuroectodermal tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

Implication of TAp73 in the p53-independent pathway of Puma induction and Puma-dependent apoptosis in primary cortical neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

Small-molecule MDM2 antagonists as a new therapy concept for neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

Melanocytic differentiation of human neuroblastoma: expression of a human melanosome-associated antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

NQO1 stabilizes p53 through a distinct pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

Flavonoid quercetin sensitizes a CD95-resistant cell line to apoptosis by activating protein kinase Calpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

Quercetin and anti-CD95(Fas/Apo1) enhance apoptosis in HPB-ALL cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

Disposition of quercetin in man after single oral and intravenous doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

Absorption of three wine-related polyphenols in three different matrices by healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

Co-administration of quercetin and catechin in rats alters their absorption but not their metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

Anti- and prooxidant effects of chronic quercetin administration in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

Long-term combined administration of quercetin and daidzein inhibits quercetin-induced suppression of glutathione antioxidant defenses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

Evaluation of the potential in vivo genotoxicity of quercetin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410391661

21 January 2018

Identifiers

DOI

10.1177/1534735410391661

1 reference

23 August 2017

1 reference